Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ventritex Cadence reprogramming effort covers 2,000 devices thus far, company reports.

This article was originally published in The Gray Sheet

Executive Summary

VENTRITEX CADENCE ICD RECALL: 2,000 DEVICES REPROGRAMMED to date, Ventritex President and CEO Frank Fischer told analysts Jan. 23 during a conference call. The call, held to review the firm's second quarter financial results, focused primarily on the Sunnyvale, California firm's progress in addressing a pacing malfunction with its Cadence V-110 models that was associated with two cases of "lethal ventricular tachyarrhythmias."
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007470

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel